Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

156 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Novel Chimeric Peptides Based on the Enolase Peptide Antigen (CEP-1) Bearing Three Post-Translational Modifications (Citrullination, Homocitrullination and Acetylation) for Determining the Diagnosis and Severity of Rheumatoid Arthritis.
Gómara MJ, Sarmiento-Monroy JC, Castellanos-Moreira R, Gómez-Puerta JA, Sanmartí R, Haro I. Gómara MJ, et al. Among authors: gomez puerta ja. Int J Mol Sci. 2024 Oct 3;25(19):10654. doi: 10.3390/ijms251910654. Int J Mol Sci. 2024. PMID: 39408982 Free PMC article.
Update of the Consensus Statement of the Spanish Society of Rheumatology on the use of biological and synthetic targeted therapies in rheumatoid arthritis.
Álvaro-Gracia Álvaro JM, Díaz Del Campo Fontecha P, Andréu Sánchez JL, Balsa Criado A, Cáliz Cáliz R, Castrejón Fernández I, Corominas H, Gómez Puerta JA, Manrique Arija S, Mena Vázquez N, Ortiz García A, Plasencia Rodríguez C, Silva Fernández L, Tornero Molina J. Álvaro-Gracia Álvaro JM, et al. Among authors: gomez puerta ja. Reumatol Clin (Engl Ed). 2024 Oct;20(8):423-439. doi: 10.1016/j.reumae.2024.09.002. Epub 2024 Sep 27. Reumatol Clin (Engl Ed). 2024. PMID: 39341701 Free article.
Predictors of first hospitalization due to disease activity and infections in systemic lupus erythematosus patients.
Pons-Estel GJ, Quintana R, Ugarte-Gil MF, Harvey GB, Wojdyla D, Serrano-Morales R, Gómez Puerta JA, García MA, Catoggio LJ, Saurit V, Drenkard C, Da Silva NA, Cavalcanti F, Borba E, Sato E, Neira O, Massardo L, Vásquez G, Gonzalez LA, Guibert-Toledano M, Silveira LH, García De La Torre I, Sauza Del Pozo MJ, Chacón R, Cardiel MH, Orillion A, Sbarigia U, Alemao E, Zazzetti F, Alarcón GS, Pons-Estel BA. Pons-Estel GJ, et al. Among authors: gomez puerta ja. Lupus. 2024 Nov;33(13):1492-1501. doi: 10.1177/09612033241283551. Epub 2024 Sep 11. Lupus. 2024. PMID: 39259025 Free PMC article.
Development of the 2023 ACR/EULAR Antiphospholipid Syndrome Classification Criteria, Phase III-D Report: Multicriteria Decision Analysis.
Barbhaiya M, Zuily S, Amigo MC, Andrade D, Avcin T, Bertolaccini ML, Branch DW, Costedoat-Chalumeau N, Crowther M, Ramires de Jesus G, Devreese KMJ, Frances C, Garcia D, Gómez-Puerta JA, Guillemin F, Levine SR, Levy RA, Lockshin MD, Ortel TL, Petri M, Sanna G, Sciascia S, Seshan SV, Tektonidou MG, Wahl D, Willis R, Yelnik C, Hendry A, Naden R, Costenbader K, Erkan D; ACR/EULAR APS Classification Criteria Collaborators. Barbhaiya M, et al. Among authors: gomez puerta ja. Arthritis Care Res (Hoboken). 2024 Dec;76(12):1617-1625. doi: 10.1002/acr.25415. Epub 2024 Sep 30. Arthritis Care Res (Hoboken). 2024. PMID: 39135467
Axial Disease in Psoriatic Arthritis: A Challenging Domain in Clinical Practice.
Alascio L, Azuaga-Piñango AB, Frade-Sosa B, Sarmiento-Monroy JC, Ponce A, Farietta S, Gómez-Puerta JA, Sanmartí R, Cañete JD, Ramírez J. Alascio L, et al. Among authors: gomez puerta ja. Diagnostics (Basel). 2024 Jul 30;14(15):1637. doi: 10.3390/diagnostics14151637. Diagnostics (Basel). 2024. PMID: 39125513 Free PMC article. Review.
OMERACT systemic lupus erythematosus domain survey.
Nielsen W, Strand V, Simon L, Pinsker E, Bonilla D, Morand E, Thumboo J, Aringer M, Mosca M, Bruce I, Parodis I, Kim A, Desai M, Enman Y, Shea B, Wallace DJ, Chaichian Y, Navarra S, Aranow C, Mackay M, Trotter K, Tayer-Shifman OE, Duarte-García A, Shan Tam L, Ugarte-Gil MF, Pons-Estel GJ, Reynolds JA, Nikpour M, Hoi A, Romero-Diaz J, Aggarwal A, Mok CC, Fujio K, Ramsey-Goldman R, Gladman DD, Arnaud L, Bultink IEM, Ruiz-Irastorza G, Inês LS, Appenzeller S, Dobrowolski C, Clarke AE, Kamen DL, Barraclough M, Tani C, Gómez-Puerta JA, Werth VP, Katz P, Nowrouzi-Kia B, Johnson SR, Drucker AM, Touma Z; OMERACT SLE Working Group. Nielsen W, et al. Among authors: gomez puerta ja. Semin Arthritis Rheum. 2024 Oct;68:152520. doi: 10.1016/j.semarthrit.2024.152520. Epub 2024 Jul 24. Semin Arthritis Rheum. 2024. PMID: 39106780
Exploring the Interplay between Cellular Senescence, Immunity, and Fibrosing Interstitial Lung Diseases: Challenges and Opportunities.
Hernandez-Gonzalez F, Pietrocola F, Cameli P, Bargagli E, Prieto-González S, Cruz T, Mendoza N, Rojas M, Serrano M, Agustí A, Faner R, Gómez-Puerta JA, Sellares J. Hernandez-Gonzalez F, et al. Among authors: gomez puerta ja. Int J Mol Sci. 2024 Jul 10;25(14):7554. doi: 10.3390/ijms25147554. Int J Mol Sci. 2024. PMID: 39062798 Free PMC article. Review.
Clinical and structural damage outcomes in axial spondyloarthritis patients receiving NSAIDs or advanced therapies: a description of a real-life cohort.
Mocritcaia A, Chacur C, Adao Abe CD, Azuaga-Piñango AB, Frade-Sosa B, Sarmiento-Monroy JC, Alascio L, Gómez-Puerta JA, Sanmartí R, Cañete JD, Ramírez J. Mocritcaia A, et al. Among authors: gomez puerta ja. Front Med (Lausanne). 2024 Jun 20;11:1425449. doi: 10.3389/fmed.2024.1425449. eCollection 2024. Front Med (Lausanne). 2024. PMID: 38966536 Free PMC article.
Factors associated with disease flare following SARS-CoV-2 vaccination in people with inflammatory rheumatic and musculoskeletal diseases: results from the physician-reported EULAR Coronavirus Vaccine (COVAX) Registry.
Farisogullari B, Lawson-Tovey S, Hyrich KL, Gossec L, Carmona L, Strangfeld A, Mateus EF, Schäfer M, Rodrigues A, Hachulla E, Gomez-Puerta JA, Mosca M, Durez P, Trefond L, Goulenok T, Cornalba M, Stenova E, Bulina I, Strakova E, Zepa J, Roux N, Brocq O, Veillard E, Raffeiner B, Burmester GR, Mariette X, Machado PM; EULAR COVAX Registry. Farisogullari B, et al. Among authors: gomez puerta ja. Ann Rheum Dis. 2024 Oct 21;83(11):1584-1595. doi: 10.1136/ard-2024-225869. Ann Rheum Dis. 2024. PMID: 38816065 Free PMC article.
Can the Dose of Belimumab be Reduced in Patients with Systemic Lupus Erythematosus?
Rua-Figueroa I, Altabás-González I, Mouriño C, Roberts K, Hernández-Martín A, Casafont-Solé I, Font-Urgelles J, Román-Ivorra JA, Navarro MR, Galindo-Izquierdo M, Salman-Monte TC, Narváez J, Vidal-Montal P, García-Villanueva MJ, Garrote-Corral S, Blazquez-Canamero MA, Fernandez-Cid CM, Piqueras-García M, Martínez-Barrio J, Sánchez-Lucas M, Cortés-Hernández J, Penzo E, Calvo J, de Dios JR, Alvarez-Rodríguez B, Vasques-Rocha M, Tomero E, Menor-Almagro R, Gandía M, Gómez-Puerta JA, Frade-Sosa B, Ramos-Giráldez C, Trapero-Pérez C, Diez E, Moriano C, Muñoz-Jiménez A, Pego-Reigosa JM. Rua-Figueroa I, et al. Among authors: gomez puerta ja. Rheumatology (Oxford). 2024 May 13:keae270. doi: 10.1093/rheumatology/keae270. Online ahead of print. Rheumatology (Oxford). 2024. PMID: 38741198
156 results